A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Lorlatinib Impurity 13 | CAS 2857871-77-1 - Request Quote

Picture of Lorlatinib Impurity 13

Lorlatinib Impurity 13

SZ CAT No:SZ-L054018
CAS No
2857871-77-1
Mol.F.
C24H25FN6O3
Mol.Wt.
464.5
Inv. Status
Synthesis on demand

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Lorlatinib Impurity 13 is chemically . Lorlatinib Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Lorlatinib Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lorlatinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2857871-77-1

Purchase 2857871-77-1

Order 2857871-77-1

Enquire 2857871-77-1

price of 2857871-77-1

2857871-77-1 Supplier

2857871-77-1 Manufacturer

2857871-77-1 Exporter

buy high quality Lorlatinib Impurity 13

Purchase Lorlatinib Impurity 13

Lorlatinib Impurity 13 suppliers

Lorlatinib Impurity 13 manufacturers

Lorlatinib Impurity 13 price

Order Lorlatinib Impurity 13

Enquire Lorlatinib Impurity 13

Lorlatinib Impurity 13 cost

Lorlatinib Impurity 13 Supplier

Lorlatinib Impurity 13 Distributor

Lorlatinib Impurity 13 for Method Validation

Lorlatinib Reference Standard

Lorlatinib Impurity 13 for ANDA Filing

Lorlatinib Impurity 13 for Forced Degradation Studies

Lorlatinib Impurity 13 Identification Standards

Lorlatinib Impurity 13 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,